Marreddy, R. K., Wu, X., Sapkota, M., Prior, A. M., Jones, J. A., Sun, D., . . . Hurdle, J. G. (2018). The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) is a Target for Narrow-Spectrum Antibacterials for Clostridium difficile Infection. ACS Infect Dis.

Marreddy, Ravi K.R., Xiaoqian Wu, Madhab Sapkota, Allan M. Prior, Jesse A. Jones, Dianqing Sun, Kirk E. Hevener, und Julian G. Hurdle. "The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) Is a Target for Narrow-Spectrum Antibacterials for Clostridium Difficile Infection." ACS Infect Dis 2018.

Marreddy, Ravi K.R., et al. "The Fatty Acid Synthesis Protein Enoyl-ACP Reductase II (FabK) Is a Target for Narrow-Spectrum Antibacterials for Clostridium Difficile Infection." ACS Infect Dis 2018.